Sanofi

News

Coronavirus vaccine: how pharma is picking up the pace

Hot shots named in Trump’s Warp Speed drive for coronavirus ...

President Donald Trump’s Operation Warp Speed, which aims to make a coronavirus vaccine widely available by year-end, has come up with a shortlist of candidates, with some nota

News

Sanofi's multiple myeloma drug approved in EU

Sanofi’s new multiple myeloma drug Sarclisa (isatuximab) has been approved in the EU for relapsed/refractory disease, taking on Johnson & Johnson’s well-established blockbuster Darzalex

News

Sanofi appoints new chief digital officer in C-Suite revamp

Sanofi's new CEO Paul Hudson has completed his revamp of the company’s executive committee, including the appointment of a dedicated chief digital officer.

News

Sanofi sheds Regeneron stake, but insists collaboration is u...

Sanofi and Regeneron’s once close relationship has been become a little more distant over the last couple of years, and the process continued this week after Sanofi said it wil

News

Sanofi CEO courts controversy after saying US is first in li...

Sanofi’s CEO Paul Hudson has courted controversy by saying the French pharma’s potential COVID-19 vaccine will likely be delivered to the US government first should it succeed in clinical t

News

Sanofi builds case for Sarclisa, challenging J&J’s Darzalex

Sanofi is trumpeting new data for its anti-CD38 drug Sarclisa as it tries to capture market share from Johnson & Johnson’s blockbuster Darzalex in the multiple myeloma mark

Hot shots named in Trump’s Warp Speed drive for coronavirus ...

Sanofi's multiple myeloma drug approved in EU

Sanofi appoints new chief digital officer in C-Suite revamp

Sanofi sheds Regeneron stake, but insists collaboration is u...

Sanofi CEO courts controversy after saying US is first in li...

Sanofi builds case for Sarclisa, challenging J&J’s Darzalex

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Sanofi

Editor's Picks